An observational study in Stroke, sponsored by Jose Romano, MD. Terminated at 1 site in United States. Open to participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-02-07.
Sponsored by Jose Romano, MD · Observational
The objective of this SAMMPRIS-affiliated study is to understand the mechanisms the mechanisms that underlie ischemic stroke recurrence in high-grade intracranial atherosclerotic disease in order to determine predictors of recurrent stroke. MoSIS will evaluate 6 specific mechanisms of stroke in the medically-treated SAMMPRIS cohort: decreased antegrade flow, progression of stenosis, decreased proximal collateral flow, decreased distal collateral flow, impaired cerebrovascular reserve, and artery-to-artery embolism.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 100 is below the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →This is the only study on the registry with Jose Romano, MD as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Medical arm of the SAMMPRIS trial which includes recently symptomatic (\<30 days) high grade (70% or more)intracranial stenosis of the carotid, middle cerebral, vertebral or basilar arteries.
Exclusion Criteria:
Ischemic stroke in the territory of the stenotic artery
Time frame: 2 years from enrollment
This study is terminated, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.